Extended prophylaxis against venous thromboembolism following total hip and knee replacement

Haemostasis

Volumn 29, Issue SUPPL. 1, 1999, Pages 23-31

  Hull, Russell D ^a   Pineo, Graham F ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Low molecular weight heparin; Orthopaedic; Thromboprophylaxis; Venous thromboembolism

Indexed keywords

DALTEPARIN; DEXTRAN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; WARFARIN;

CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; KNEE ARTHROPLASTY; LENGTH OF STAY; ORTHOPEDIC SURGERY; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; PROPHYLAXIS; THROMBOEMBOLISM; TOTAL HIP PROSTHESIS;

EID: 0033392086     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054109     Document Type: Conference Paper

References (25)

1. Kakkar VV, Howe CT, Flank C, Clarke MB: Natural history of post-operative deep-vein thrombosis. Lancet 1969;ii:230-232.
2. Turpie AGG, Levine M, Hirsh J, Carter CJ, Jay RM, Powers PJ, Andrew M, Hull RD, Gent M: A randomized controlled trial of a lowmolecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 1986;315: 925-929.
3. Scurr JH: How long after surgery does the risk of thromboembolism persist? Acta Chir Scand Suppl 1990;556:22-24.
4. Guyatt GH, Cook DJ, Sacket DL, Eckman M, Pauker S: Grades of recommendation for antithrombotic agents. Chest 1998;114:441S-444S.
5. LeLorier J, Gregoire G, Benhaddad A, Lapierre J, Derderian F: Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 1997; 337:536-542.
6. Hull RD, Pineo GF: Clinical features of deep venous thrombosis; in Hull RD, Raskob GE, Pineo GF (eds): Venous Thromboembolism: An Evidence Based Atlas. Amonk, Futura Publishing, 1996, pp 87-91.
7. Seagroatt V, Tan HS, Goldacre M, Bulstrode C, Nugent I, Gill L: Elective total hip replacement: Incidence emergency readmission rate, and post-operative mortality. BMJ 1991;303:1431-1435.
8. Warwick D, Williams MH, Bannister GC: Death and thromboembolic disease after total hip replacement. J Bone Joint Surg Br 1995;77:6-10.
9. Linbald B, Eriksson BT, Bergqvist D: Autopsy-verified pulmonary embolism in a surgical department: Analysis of the period from 1951 to 1988. Br J Surg 1991;78:849-852.
10. Campling EA, Devlin HB, Hoile RW, Lunn JN: The report of the National Confidential Enquiry into Perioperative Deaths 1991/1992. London, The National Confidential Enquiry into Perioperative Deaths, 1993.
11. Mohr DN, Silverstein MD, Murtaugh PA, Harrison JM: Prophylactic agents for venous thrombosis in elective hip surgery. Arch Intern Med 1993;153:2221-2228.
12. Robinson KS, Anderson D, Gross M, Petrie D, Leighton R, Stanish W, Alexander D, Mitchell M, Flemming B, Gent M: Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: The Post-Arthroplasty Screening Study. Ann Intern Med 1997;127:439-445.
13. Lieberman JR, Wollaeger J, Dorey F, Thomas BJ, Kilgus DJ, Grecula MJ, Finerman GA, Amstutz HC: The efficacy of prophylaxis with low-dose warfarin for prevention of pulmonary embolism following total hip arthroplasty. J Bone Joint Surg Am 1997;79:319-325.
14. Leclerc J, Gent M, Hirsh J, Geerts WH, Ginsberg JS: The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin. A multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Arch Intern Med 1988;158:873-878.
15. Colwell CW Jr, Collis DK, Paulson R, McCutchen JW, Bigler GT, Lutz S, Hardwick ME: Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge. J Bone Joint Surg Am 1999;81:932-940.
16. Lassen M, Borris LC, Christiansen HM, Boll KL, Eiskjaer SP, Nielsen BW, Schott P, Olsen AD, Rodenberg JC, Lucht U: Prevention of thromboembolism in 190 hip arthroplasties: comparison of LMW heparin and placebo. Acta Orthop Scand 1991;62:33-38.
17. Hull RD, Raskob GE, Gent M, McLoughlin D, Julian D, Smith FCM, Dale NI, Reed-Davis R, Lofthouse RN, Anderson C: Effectiveness of intermittent pneumatic leg compression for preventing DVT after total hip replacement. J Am Med Assoc 1990;263:2313-2317.
18. Bergqvist D, Benoni G, Bjorgell O, Fredin H, Hedlundh U, Nicolas S, Nillson P, Nylander G: Low-molecular-weight heparin (enoxaparin) as prophylaxis against thromboembolism after total hip replacement. N Engl J Med 1996;335:696-700.
19. Planes A, Vocehlle N, Darmon J-Y, Fagola M, Bellaud M, Huet Y: Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: Double-blind randomised comparison of enoxaparin versus placebo. Lancet 1996;348:224-228.
20. Dahl OE, Andreassen G, Aspelin T, Muller C, Mathiesen P, Nyhus S, Abdelnoor M, Solhaug JH, Amesen H: Prolonged thromboprophylaxis following hip replacement surgery - results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin). Thromb Haemost 1997;77:26-31.
21. Lassen MR, Borris LC, Anderson BS, Jensen HP, Skejo Bro HP, Andersen G, Petersen AO, Siem P, Horlyck E, Jensen BV, Thomsen PB, Hansen BR, Erin-Madsen J, Moller JC, Rotwitt L, Christensen F, Nielsen JB, Jorgensen PS, Paaske B, Torholm C, Hvidt P, Jensen NK, Nielsen AB, Appelquist E, Tjalve E: Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty - the Danish Prolonged Prophylaxis (DaPP) Study. Thromb Res 1998; 89:281-287.
22. Hull RD, Brant RF, Pineo GF, Stein PD, Raskob GE, Valentine KA: Preoperative vs post-operative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement. Arch Intern Med 1999;159:137-141.
23. Pineo GF, Hull RD: A comparison of pre-operative dalteparin with post-operative dalteparin and with warfarin sodium for prophylaxis against DVT after total hip replacement during the acute hospital stay. Thromb Haemost 1999(suppl):Abstract 1194.
24. Hull RD, Raskob GE, Brant RF, Pineo GF: Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of patients with pulmonary embolism and underlying proximal deep-vein thrombosis. Thromb Haemost 1999(suppl):Abstract 19.
25. Clagget CP, Anderson FA, Geerts W, Heit JA, Knudson M, Lieberman JR, Merli G, Wheler HB: Prevention of venous thromboembolism. Chest 1998;114:531S-560S.